These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 29415871)

  • 1. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
    Pazdera L; Sperling MR; Harvey JH; Sam MC; Strom LA; Blum D; Grinnell T; Cheng H
    Epilepsia; 2018 Mar; 59(3):704-714. PubMed ID: 29450890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
    Stephen LJ; Wishart A; Brodie MJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy.
    Chen B; Detyniecki K; Choi H; Hirsch L; Katz A; Legge A; Wong R; Jiang A; Buchsbaum R; Farooque P
    Eur J Paediatr Neurol; 2017 May; 21(3):441-449. PubMed ID: 28238621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial.
    Aboumatar S; Krishnaiengar SR; Cantu D; Zhang Y; Grinnell T
    Clin Neurol Neurosurg; 2023 Feb; 225():107552. PubMed ID: 36657359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?
    Sarangi SC; Kaur N; Tripathi M
    Epilepsy Behav; 2019 Nov; 100(Pt A):106439. PubMed ID: 31574428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].
    Losch FP; Holtkamp M; McMurray R; Lendemans D; Kockelmann E
    Nervenarzt; 2016 Oct; 87(10):1094-1099. PubMed ID: 27550387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of anger in epilepsy patients treated with eslicarbazepine acetate.
    Toledo M; Mazuela G; Mauri JA; Rodriguez-Osorio X; Gómez-Eguilaz M; Castro-Vilanova D; Rodriguez-Uranga J; Santamarina E
    Acta Neurol Scand; 2019 Jul; 140(1):48-55. PubMed ID: 30953593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
    Andermann E; Biton V; Benbadis SR; Shneker B; Shah AK; Carreño M; Trinka E; Ben-Menachem E; Biraben A; Rocha F; Gama H; Cheng H; Blum D;
    Epilepsy Behav; 2018 May; 82():119-127. PubMed ID: 29604484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
    Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
    Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
    Serrano-Castro PJ; Payán-Ortiz M; Cimadevilla JM; Quiroga-Subirana P; Fernández-Pérez J
    Rev Neurol; 2013 Mar; 56(6):309-14. PubMed ID: 23483464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with eslicarbazepine acetate in adults with sub-analysis of elderly.
    Nielsen MK; Petrenaite V; Andersen NB
    Seizure; 2017 Dec; 53():94-99. PubMed ID: 29172139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study.
    Villanueva V; Serratosa JM; Guillamón E; Garcés M; Giráldez BG; Toledo M; Salas-Puig J; López González FJ; Flores J; Rodríguez-Uranga J; Castillo A; Mauri JA; Camacho JL; López-Gomáriz E; Giner P; Torres N; Palau J; Molins A
    Epilepsy Res; 2014 Sep; 108(7):1243-52. PubMed ID: 24908564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam-Associated Psychogenic Non-epileptic Seizures; A Hidden Paradox.
    Jabeen SA; Gaddamanugu P; Cherian A; Mridula KM; Kumar DU; Meena AK
    J Popul Ther Clin Pharmacol; 2018 Jul; 25(2):e1-e11. PubMed ID: 30725538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
    Sunkaraneni S; Ludwig EA; Passarell JA; Blum D; Grinnell T; Fiedler-Kelly J
    J Clin Pharmacol; 2018 Jul; 58(7):927-938. PubMed ID: 29528499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
    Mäkinen J; Rainesalo S; Peltola J
    Brain Behav; 2017 Mar; 7(3):e00634. PubMed ID: 28293474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
    Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
    Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.
    Hixson J; Gidal B; Pikalov A; Zhang Y; Mehta D; Blum D; Cantu D; Grinnell T;
    Epilepsy Res; 2021 Mar; 171():106561. PubMed ID: 33556737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.